Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).
In the last several years, global market of Sickle Cell Anemia Therapeutics developed rapidly, with an average growth rate of 13% during 2015 to 2019. In 2019, global revenue of Sickle Cell Anemia Therapeutics is nearly 1900 M USD.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Sickle-cell Anemia Therapeutics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Sickle-cell Anemia Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Sickle-cell Anemia Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Bristol-Myers Squibb
Mast Therapeutics
Merck Sharp and Dohme
Daiichi Sankyo
Baxter
Bluebird Bio
Selexys Pharmaceuticals
Pfizer
Emmaus Medical
GlycoMimetics
Eli Lilly
HemaQuest Pharmaceuticals
By Type:
Vaccination and Antibiotics
High Fluid Intake
Folic Acid Supplementation
Pain Medication
Other
By End-User:
Hospitals
Clinics
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Sickle-cell Anemia Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Vaccination and Antibiotics from 2016 to 2027
-
1.3.2 USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of High Fluid Intake from 2016 to 2027
-
1.3.3 USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Folic Acid Supplementation from 2016 to 2027
-
1.3.4 USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Pain Medication from 2016 to 2027
-
1.3.5 USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Sickle-cell Anemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Sickle-cell Anemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Sickle-cell Anemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Sickle-cell Anemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Sickle-cell Anemia Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Sickle-cell Anemia Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Vaccination and Antibiotics
-
3.4.2 Market Size and Growth Rate of High Fluid Intake
-
3.4.3 Market Size and Growth Rate of Folic Acid Supplementation
-
3.4.4 Market Size and Growth Rate of Pain Medication
-
3.4.5 Market Size and Growth Rate of Other
4 Segmentation of Sickle-cell Anemia Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Sickle-cell Anemia Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Sickle-cell Anemia Therapeutics in Hospitals
-
4.4.2 Market Size and Growth Rate of Sickle-cell Anemia Therapeutics in Clinics
-
4.4.3 Market Size and Growth Rate of Sickle-cell Anemia Therapeutics in Other
5 Market Analysis by Regions
-
5.1 USA Sickle-cell Anemia Therapeutics Production Analysis by Regions
-
5.2 USA Sickle-cell Anemia Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Sickle-cell Anemia Therapeutics Landscape Analysis
-
6.1 West USA Sickle-cell Anemia Therapeutics Landscape Analysis by Major Types
-
6.2 West USA Sickle-cell Anemia Therapeutics Landscape Analysis by Major End-Users
7 South USA Sickle-cell Anemia Therapeutics Landscape Analysis
-
7.1 South USA Sickle-cell Anemia Therapeutics Landscape Analysis by Major Types
-
7.2 South USA Sickle-cell Anemia Therapeutics Landscape Analysis by Major End-Users
8 Middle West USA Sickle-cell Anemia Therapeutics Landscape Analysis
-
8.1 Middle West USA Sickle-cell Anemia Therapeutics Landscape Analysis by Major Types
-
8.2 Middle West USA Sickle-cell Anemia Therapeutics Landscape Analysis by Major End-Users
9 Northeast USA Sickle-cell Anemia Therapeutics Landscape Analysis
-
9.1 Northeast USA Sickle-cell Anemia Therapeutics Landscape Analysis by Major Types
-
9.2 Northeast USA Sickle-cell Anemia Therapeutics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Bristol-Myers Squibb
-
10.1.1 Bristol-Myers Squibb Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Mast Therapeutics
-
10.2.1 Mast Therapeutics Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Merck Sharp and Dohme
-
10.3.1 Merck Sharp and Dohme Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Daiichi Sankyo
-
10.4.1 Daiichi Sankyo Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Baxter
-
10.5.1 Baxter Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Bluebird Bio
-
10.6.1 Bluebird Bio Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Selexys Pharmaceuticals
-
10.7.1 Selexys Pharmaceuticals Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Pfizer
-
10.8.1 Pfizer Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Emmaus Medical
-
10.9.1 Emmaus Medical Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 GlycoMimetics
-
10.10.1 GlycoMimetics Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Eli Lilly
-
10.11.1 Eli Lilly Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 HemaQuest Pharmaceuticals
-
10.12.1 HemaQuest Pharmaceuticals Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Vaccination and Antibiotics from 2016 to 2027
-
Figure USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of High Fluid Intake from 2016 to 2027
-
Figure USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Folic Acid Supplementation from 2016 to 2027
-
Figure USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Pain Medication from 2016 to 2027
-
Figure USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure USA Sickle-cell Anemia Therapeutics Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Sickle-cell Anemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Sickle-cell Anemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Sickle-cell Anemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Sickle-cell Anemia Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Sickle-cell Anemia Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Sickle-cell Anemia Therapeutics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Sickle-cell Anemia Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Sickle-cell Anemia Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Vaccination and Antibiotics
-
Figure Market Size and Growth Rate of High Fluid Intake
-
Figure Market Size and Growth Rate of Folic Acid Supplementation
-
Figure Market Size and Growth Rate of Pain Medication
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Sickle-cell Anemia Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Sickle-cell Anemia Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Other
-
Table USA Sickle-cell Anemia Therapeutics Production by Regions
-
Table USA Sickle-cell Anemia Therapeutics Production Share by Regions
-
Figure USA Sickle-cell Anemia Therapeutics Production Share by Regions in 2016
-
Figure USA Sickle-cell Anemia Therapeutics Production Share by Regions in 2021
-
Figure USA Sickle-cell Anemia Therapeutics Production Share by Regions in 2027
-
Table USA Sickle-cell Anemia Therapeutics Consumption by Regions
-
Table USA Sickle-cell Anemia Therapeutics Consumption Share by Regions
-
Figure USA Sickle-cell Anemia Therapeutics Consumption Share by Regions in 2016
-
Figure USA Sickle-cell Anemia Therapeutics Consumption Share by Regions in 2021
-
Figure USA Sickle-cell Anemia Therapeutics Consumption Share by Regions in 2027
-
Table West USA Sickle-cell Anemia Therapeutics Consumption by Types from 2016 to 2027
-
Table West USA Sickle-cell Anemia Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure West USA Sickle-cell Anemia Therapeutics Consumption Share by Types in 2016
-
Figure West USA Sickle-cell Anemia Therapeutics Consumption Share by Types in 2021
-
Figure West USA Sickle-cell Anemia Therapeutics Consumption Share by Types in 2027
-
Table West USA Sickle-cell Anemia Therapeutics Consumption by End-Users from 2016 to 2027
-
Table West USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users in 2016
-
Figure West USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users in 2021
-
Figure West USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users in 2027
-
Table South USA Sickle-cell Anemia Therapeutics Consumption by Types from 2016 to 2027
-
Table South USA Sickle-cell Anemia Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South USA Sickle-cell Anemia Therapeutics Consumption Share by Types in 2016
-
Figure South USA Sickle-cell Anemia Therapeutics Consumption Share by Types in 2021
-
Figure South USA Sickle-cell Anemia Therapeutics Consumption Share by Types in 2027
-
Table South USA Sickle-cell Anemia Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users in 2016
-
Figure South USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users in 2021
-
Figure South USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users in 2027
-
Table Middle West USA Sickle-cell Anemia Therapeutics Consumption by Types from 2016 to 2027
-
Table Middle West USA Sickle-cell Anemia Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Sickle-cell Anemia Therapeutics Consumption Share by Types in 2016
-
Figure Middle West USA Sickle-cell Anemia Therapeutics Consumption Share by Types in 2021
-
Figure Middle West USA Sickle-cell Anemia Therapeutics Consumption Share by Types in 2027
-
Table Middle West USA Sickle-cell Anemia Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users in 2016
-
Figure Middle West USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users in 2021
-
Figure Middle West USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast USA Sickle-cell Anemia Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast USA Sickle-cell Anemia Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Sickle-cell Anemia Therapeutics Consumption Share by Types in 2016
-
Figure Northeast USA Sickle-cell Anemia Therapeutics Consumption Share by Types in 2021
-
Figure Northeast USA Sickle-cell Anemia Therapeutics Consumption Share by Types in 2027
-
Table Northeast USA Sickle-cell Anemia Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast USA Sickle-cell Anemia Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Mast Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mast Therapeutics
-
Figure Sales and Growth Rate Analysis of Mast Therapeutics
-
Figure Revenue and Market Share Analysis of Mast Therapeutics
-
Table Product and Service Introduction of Mast Therapeutics
-
Table Company Profile and Development Status of Merck Sharp and Dohme
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Sharp and Dohme
-
Figure Sales and Growth Rate Analysis of Merck Sharp and Dohme
-
Figure Revenue and Market Share Analysis of Merck Sharp and Dohme
-
Table Product and Service Introduction of Merck Sharp and Dohme
-
Table Company Profile and Development Status of Daiichi Sankyo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo
-
Figure Sales and Growth Rate Analysis of Daiichi Sankyo
-
Figure Revenue and Market Share Analysis of Daiichi Sankyo
-
Table Product and Service Introduction of Daiichi Sankyo
-
Table Company Profile and Development Status of Baxter
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter
-
Figure Sales and Growth Rate Analysis of Baxter
-
Figure Revenue and Market Share Analysis of Baxter
-
Table Product and Service Introduction of Baxter
-
Table Company Profile and Development Status of Bluebird Bio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bluebird Bio
-
Figure Sales and Growth Rate Analysis of Bluebird Bio
-
Figure Revenue and Market Share Analysis of Bluebird Bio
-
Table Product and Service Introduction of Bluebird Bio
-
Table Company Profile and Development Status of Selexys Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Selexys Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Selexys Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Selexys Pharmaceuticals
-
Table Product and Service Introduction of Selexys Pharmaceuticals
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Emmaus Medical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emmaus Medical
-
Figure Sales and Growth Rate Analysis of Emmaus Medical
-
Figure Revenue and Market Share Analysis of Emmaus Medical
-
Table Product and Service Introduction of Emmaus Medical
-
Table Company Profile and Development Status of GlycoMimetics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlycoMimetics
-
Figure Sales and Growth Rate Analysis of GlycoMimetics
-
Figure Revenue and Market Share Analysis of GlycoMimetics
-
Table Product and Service Introduction of GlycoMimetics
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of HemaQuest Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of HemaQuest Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of HemaQuest Pharmaceuticals
-
Figure Revenue and Market Share Analysis of HemaQuest Pharmaceuticals
-
Table Product and Service Introduction of HemaQuest Pharmaceuticals
-
